跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
epidermal growth factor
首页
药物
epidermal growth factor
epidermal growth factor
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Recombinant anti-epidermal growth factor receptor antibody compositions
US 7887805 B2
申请人: SYMPHOGEN AS
优先权: 2007
CN
US
6 件公开
US 2011229463 A1
申请人: SYMPHOGEN AS
优先权: 2009
US
2 件公开
Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
US 7851601 B2
申请人: KYOWA HAKKO KIRIN CO LTD
优先权: 2006
US
6 件公开
US 8163282 B2
申请人: MEKADA EISUKE
优先权: 2009
US
3 件公开
FUNCTIONAL MONOCLONAL ANTIBODY AGAINST HEPARIN-BINDING EPIDERMAL GROWTH FACTOR-LIKE GROWTH FACTOR
EP 2990418 B1
申请人: MEDICAL & BIOLOGICAL LABORATORIES CO LTD
优先权: 2013
EP
US
WO
5 件公开
MODULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR LIGANDS
US 2013090366 A1
申请人: LEEDMAN PETER JEFFERY
优先权: 2009
CN
US
5 件公开
ANTIBODIES FOR EPIDERMAL GROWTH FACTOR RECEPTOR 3 (HER3)
EP 3590538 A1
申请人: NOVARTIS AG
优先权: 2011
EP
US
5 件公开
US 8735551 B2
申请人: GARNER ANDREW PAUL
优先权: 2011
US
3 件公开
Human anti-epidermal growth factor receptor single-chain antibodies
US 7045127 B2
申请人: UAB RESEARCH FOUNDATION
优先权: 2001
US
5 件公开
Human monoclonal antibodies to epidermal growth factor receptor
US 2005100546 A1
申请人: ABGENIX INC
优先权: 2004
US
5 件公开
EPIDERMAL GROWTH FACTOR RECEPTOR
US 2023174622 A1
申请人: OSPEDALE SAN RAFFAELE SRL
优先权: 2020
CN
EP
US
WO
4 件公开
EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS
US 20260028374 A1
申请人: FILAMON LTD
优先权: 2023
CN
EP
US
WO
4 件公开
WO 2019070167 A8
申请人: BIOCAD JOINT STOCK CO
优先权: 2017
CN
WO
2 件公开
WO 2022146201 A1
申请人: BIOCAD JOINT STOCK CO
优先权: 2020
WO
Mutations in the epidermal growth factor receptor gene
US 9765399 B2
申请人: MONTAGUT VILADOT CLARA
优先权: 2011
EP
US
4 件公开
第 1 / 9 页
上一页
下一页
药物
反馈